ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

52 links0 made here, not in the record61 judgments2 judges (the rules as one: Rule based)5 record changes seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT02465060Targeted Therapy Directedby Genetic Testing inTreating Patients WithAdvanced Refractory SolidTumors, Lymphomas, orMultiple Myeloma (The MATCHScreening Trial)National Cancer Institute (NCIPhase 2 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 29 · ClinicalTrials.gov record · Version of 2026-09-29Oct 1 · ClinicalTrials.gov record · Version of 2026-10-01Oct 22 · ClinicalTrials.gov record · Version of 2026-10-22Oct 26 · ClinicalTrials.gov record · Version of 2026-10-26Nov 12 · ClinicalTrials.gov record · Version of 2026-11-12Version of 2026-11-12CONDITIONSUrinary Bladder NeoplasmsThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionBreast NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Uterine Cervical NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Colonic NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Colorectal NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Endometrial NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Esophageal NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Pancreatic NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Stomach NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.GliomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Hematologic NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Carcinoma, Renal CellThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Carcinoma, HepatocellularThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Lung NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.LymphomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Uterine NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.MelanomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Multiple MyelomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Ovarian NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Prostatic NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Rectal NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Thyroid NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSAdavosertibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAfatinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedBinimetinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCapivasertibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCopanlisibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCopanlisib hydrochlorideIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCrizotinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedDabrafenibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedDabrafenib mesylateIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedDasatinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedDefactinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedDefactinib hydrochlorideIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedErdafitinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAZD4547Entry “Fexagratinib”, read by our nam…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedIpatasertibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedLarotrectinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedNivolumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedOsimertinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPalbociclibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPertuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedGSK2636771Entry “PI3K-beta Inhibitor GSK2636771…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedRelatlimabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedSapanisertibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedSunitinibEntry “Sunitinib Malate”, read by our…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTaselisibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTrametinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTrastuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAdo-Trastuzumab EmtansineEntry “Trastuzumab Emtansine”, read b…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedUlixertinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedHhAntag691Entry “Vismodegib”, read by our name …›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Adavosertib

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Adavosertib”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Sep 29The record itselfClinicalTrials.gov recordVersion of 2026-09-29Record change
Oct 1The record itselfClinicalTrials.gov recordVersion of 2026-10-01Record change
Oct 22The record itselfClinicalTrials.gov recordVersion of 2026-10-22Record change
Oct 26The record itselfClinicalTrials.gov recordVersion of 2026-10-26Record change
Nov 2AdavosertibClaude Opus 5.5TestedCurrent
Nov 2AfatinibClaude Opus 5.5TestedCurrent
Nov 2BinimetinibClaude Opus 5.5TestedCurrent
Nov 2CapivasertibClaude Opus 5.5TestedCurrent
Nov 2CopanlisibClaude Opus 5.5TestedCurrent
Nov 2Copanlisib hydrochlorideClaude Opus 5.5TestedCurrent
Nov 2CrizotinibClaude Opus 5.5TestedCurrent
Nov 2DabrafenibClaude Opus 5.5TestedCurrent
Nov 2Dabrafenib mesylateClaude Opus 5.5TestedCurrent
Nov 2DasatinibClaude Opus 5.5TestedCurrent
Nov 2DefactinibClaude Opus 5.5TestedCurrent
Nov 2Defactinib hydrochlorideClaude Opus 5.5TestedCurrent
Nov 2ErdafitinibClaude Opus 5.5TestedCurrent
Nov 2AZD4547Claude Opus 5.5TestedCurrent
Nov 2IpatasertibClaude Opus 5.5TestedCurrent
Nov 2LarotrectinibClaude Opus 5.5TestedCurrent
Nov 2NivolumabClaude Opus 5.5TestedCurrent
Nov 2OsimertinibClaude Opus 5.5TestedCurrent
Nov 2PalbociclibClaude Opus 5.5TestedCurrent
Nov 2PertuzumabClaude Opus 5.5TestedCurrent
Nov 2GSK2636771Claude Opus 5.5TestedCurrent
Nov 2RelatlimabClaude Opus 5.5TestedCurrent
Nov 2SapanisertibClaude Opus 5.5TestedCurrent
Nov 2SunitinibClaude Opus 5.5TestedCurrent
Nov 2TaselisibClaude Opus 5.5TestedCurrent
Nov 2TrametinibClaude Opus 5.5TestedCurrent
Nov 2TrastuzumabClaude Opus 5.5TestedCurrent
Nov 2Ado-Trastuzumab EmtansineClaude Opus 5.5TestedCurrent
Nov 2UlixertinibClaude Opus 5.5TestedCurrent
Nov 2HhAntag691Claude Opus 5.5TestedCurrent
Nov 12The record itselfClinicalTrials.gov recordVersion of 2026-11-12Record change
Nov 18AdavosertibRule based · role ruleTestedAgrees
Nov 18AfatinibRule based · role ruleTestedAgrees
Nov 18BinimetinibRule based · role ruleTestedAgrees
Nov 18CapivasertibRule based · role ruleTestedAgrees
Nov 18CopanlisibRule based · role ruleTestedAgrees
Nov 18Copanlisib hydrochlorideRule based · role ruleTestedAgrees
Nov 18CrizotinibRule based · role ruleTestedAgrees
Nov 18DabrafenibRule based · role ruleTestedAgrees
Nov 18Dabrafenib mesylateRule based · role ruleTestedAgrees
Nov 18DasatinibRule based · role ruleTestedAgrees
Nov 18DefactinibRule based · role ruleTestedAgrees
Nov 18Defactinib hydrochlorideRule based · role ruleTestedAgrees
Nov 18ErdafitinibRule based · role ruleTestedAgrees
Nov 18AZD4547Rule based · role ruleTestedAgrees
Nov 18IpatasertibRule based · role ruleTestedAgrees
Nov 18LarotrectinibRule based · role ruleTestedAgrees
Nov 18NivolumabRule based · role ruleTestedAgrees
Nov 18OsimertinibRule based · role ruleTestedAgrees
Nov 18PalbociclibRule based · role ruleTestedAgrees
Nov 18PertuzumabRule based · role ruleTestedAgrees
Nov 18GSK2636771Rule based · role ruleTestedAgrees
Nov 18RelatlimabRule based · role ruleTestedAgrees
Nov 18SapanisertibRule based · role ruleTestedAgrees
Nov 18SunitinibRule based · role ruleTestedAgrees
Nov 18TaselisibRule based · role ruleTestedAgrees
Nov 18TrametinibRule based · role ruleTestedAgrees
Nov 18TrastuzumabRule based · role ruleTestedAgrees
Nov 18Ado-Trastuzumab EmtansineRule based · role ruleTestedAgrees
Nov 18UlixertinibRule based · role ruleTestedAgrees
Nov 18HhAntag691Rule based · role ruleTestedAgrees
As of nowUrinary Bladder NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.